Key result
Higher visit-to-visit variability in total cholesterol was associated with a 15% increased risk of all-cause dementia (HR 1.15) compared to the lowest variability quartile.
Why the study?
Total cholesterol variability is a suggested risk factor for cardiovascular and cerebrovascular disease, but its association with the development of dementia had not been evaluated.
Does high visit-to-visit total cholesterol variability increase the risk of dementia in the general population?
Cohort (n=131,965)
Does high visit-to-visit total cholesterol variability increase the risk of dementia in the general population?
Higher visit-to-visit variability in total cholesterol is independently associated with an increased long-term risk of all-cause dementia and Alzheimer's disease in the general population.
Should not yet change lipid monitoring; leaves open whether cholesterol variability is a modifiable dementia risk factor.
Introduction: Although total cholesterol (TC) variability suggested for a risk factor for cardiovascular and cerebrovascular disease, there was no previous study to evaluate the association between TC variability and the development of dementia. Methods: Using the Korean National Health Insurance Service–Health Screening Cohort (NHIS-HEALS), the main outcomes were newly diagnosed all-cause dementia, Alzheimer’s disease (AD), or vascular dementia (VaD) between January 1, 2008, and December 31, 2015. Visit-to-visit TC variability was measured as variability independent of the mean (TC-VIM), coefficient variance (TC-CV), and standard deviation (TC-SD). Results: In a total of 131,965 Koreans, there were 3,722 all-cause dementia (2.82%), 2,776 AD (2.10%), and 488 VaD (0.37%) during the median follow-up of 8.4 years. Kaplan-Meier curves showed increased cumulative incidences for all in the highest quartiles of TC variability group compared to the others. Regression using Fine and Gray hazards model showed a steadily increasing risk of all-cause dementia with higher quartiles of TC variability. After adjusting for confounders including mean TC level and comparing the highest and lowest TC-VIM quartiles, the hazard ratios (HRs) for all-cause dementia and AD were 1.15 (95% confidence interval [CI] = 1.05 - 1.27; P = 0.003) and 1.12(95% CI = 1.00 - 1.25; P = 0.040), respectively. The incidence of VaD was not significantly higher in the higher-quartile groups compared to that in the lowest-quartile group in TC-VIM variability (HR 1.22; 95% CI = 0.95 - 1.59; P = 0.122). These associations were consistent with TC variability defined by TC-CV or TC-SD. Conclusions: For the first time, we have demonstrated that a higher visit-to-visit variability in TC independent of mean TC was associated with an increased risk of all-cause dementia and AD in the general population.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2019) conducted a cohort in Dementia (n=131,965). High total cholesterol variability (highest quartile) vs. Low total cholesterol variability (lowest quartile) was evaluated on Newly diagnosed all-cause dementia (HR 1.15, 95% CI 1.05-1.27, p=0.003). Higher visit-to-visit variability in total cholesterol was associated with a 15% increased risk of all-cause dementia (HR 1.15) compared to the lowest variability quartile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: